FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to ophthalmology and is intended for slowing down rough scarring of conjunctiva in carrying out photodynamic therapy in conditions of vascular proliferation of conjunctiva. First, not less than 2 mg of alasense are introduced subconjunctivally. After 1.5-2 hours impact with laser radiation with wavelength 632.8 nm, power density 47.7-55.7 mW/cm2, is performed for 10-14 minutes. 12-24 hours after intervention medication viscleron is introduced into conjunctival sac of affected eye 1 drop 3 times per day, during not fewer than 10 days.
EFFECT: method ensures efficient suppression of angiogenesis of conjunctiva vessels in zones of proliferating cells due to application of aggressive parameters of laser impact with simultaneous prevention of necrobiotic and destructive changes due to protective effect on irradiated tissues.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF SLOWING DOWN PROLIFERATION PROCESSES IN INJURED RETINA | 2010 |
|
RU2440159C1 |
METHOD OF CONSERVATIVE TREATMENT OF PTERYGIUM | 2010 |
|
RU2438631C1 |
METHOD OF CURING SUBRETINAL NEOVASCULAR MEMBRANE | 2005 |
|
RU2290973C1 |
METHOD OF TREATING 1 DEGREE PTERYGIUM | 2016 |
|
RU2613600C1 |
METHOD FOR TREATING PTERYGIUM | 2006 |
|
RU2308923C1 |
METHOD OF ORGAN-PRESERVING TREATMENT OF INTRAOCULAR TUMOURS | 2010 |
|
RU2452444C1 |
METHOD OF INFECTIOUS KERATITIS TREATMENT | 2007 |
|
RU2352367C1 |
METHOD OF PREVENTION CICATRISATION OF OUTFLOW PATHS CREATED DURING ANTI-GLAUCOMA OPERATION | 2007 |
|
RU2334496C1 |
METHOD OF TREATING LATENT SUBRETINAL NEOVASCULAR MEMBRANES | 2009 |
|
RU2395318C1 |
METHOD OF ORGAN-PRESERVING TREATMENT OF PATIENTS WITH INITIAL CARCINOMA OF VULVA | 2010 |
|
RU2445991C2 |
Authors
Dates
2012-08-20—Published
2011-02-01—Filed